According to a fresh study by experts at Dukes Preston Robert Tisch Mind Tumor Center.

Vredenburgh, M.D., a neuro-oncologist at Duke and business lead investigator on the scholarly research. The scholarly research was funded by the National Institutes of Wellness, the Preston Robert Tisch Mind Tumor Study Fund and the Bryan Cless Analysis Fund. In this pilot research, researchers administered a combined mix of irinotecan and bevacizumab, a typical chemotherapeutic agent, to 35 sufferers whose GBMs had came back. Each patient had recently been treated with a typical therapy regimen, possibly including surgery, chemotherapy and radiation. Almost half noticed no tumor progression after half a year, and nearly 80 % had been still alive half a year after diagnosis. Sufferers with recurrent GBM who are treated with regular therapies, such as for example chemotherapy alone, possess tumor progression at half a year in about 75 % of cases and less than 50 % are alive after half a year.One of the chemicals, ellagic acid, proved especially potent: It significantly slowed the growth of existing fats cells and development of new ones, and it boosted rate of metabolism of essential fatty acids in liver cells. These plant chemicals aren’t a weight-reduction miracle, cautions Shay. We didn’t find, and we didn’t be prepared to, that these compounds would improve bodyweight, he stated. But by boosting the burning of extra fat, in the liver especially, they could improve liver function in overweight people.